ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
| CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
| Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
| Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
| CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
| ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
| Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
| Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
| Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |